[Summary] One of China's Top 20 Listed Pharmaceutical Companies
Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded on June 16, 1992 (stock code: 002603). With the corporate mission of "Inheriting and Innovating for the Benefit of Humanity," the development goal of "Technological Health for Tomorrow," and the management philosophy of "Developing for Employees, Contributing to Society, and Creating Value for Shareholders," the company consistently adheres to an innovation-driven development strategy led by technology and guided by the market. It systematically established the theoretical framework of Luobing (Collateral Disease) Theory, pioneered the integrated operating model of "Theory - Clinical Practice - New Drugs - Industry - Education," and formed an industrial development cluster spanning "from medicine to healthcare to wellness." The "TCM Collateral Disease Diagnosis and Treatment Method" has been inscribed in the national intangible cultural heritage list, and "Luobingxue (Collateral Disease Theory)" has become a university textbook, taught in over 40 universities nationwide. The company has successively undertaken more than 60 national and provincial/ministerial research projects, including the National 973 Program, the National 863 Program, the National Natural Science Foundation of China, and the National Key R&D Program. The company has developed over 10 patented new drugs, including Tongxinluo Capsules for treating coronary heart disease and cerebral infarction, Shensong Yangxin Capsules for treating arrhythmias, Qili Qiangxin Capsules for chronic heart failure, Lianhua Qingwen Capsules for colds and influenza, and Bazi Bushen Capsules for tonifying kidney essence and anti-aging. It has obtained over 800 patents and has been honored with six national awards, including the First Prize and Second Prize of the National Science and Technology Progress Award. The company has established five production and R&D bases in Hebei and Beijing, built over 60 raw material medicinal herb bases nationwide, and its production workshops have passed international certifications from the United States, the European Union, Canada, New Zealand, and other countries and regions, establishing a comprehensive quality control system in line with international standards. Lianhua Qingwen is marketed in over 30 countries. Recognized as one of China's Top 10 Traditional Chinese Medicine Enterprises, one of China's Top 20 Listed Pharmaceutical Companies, one of the Top 500 Listed Companies by Market Value in China, and one of China's Top 100 Most Valuable Brands, the company was also honored by the CPC Central Committee with the title of "National Advanced Primary Party Organization."
Corporate Honors:
2020 China's Top 500 Most Valuable Brands;
Top 500 Listed Companies by Market Value in China;
National Demonstration Base for Industrialization of Achievements from the National High-Tech R&D Program;
International Science and Technology Cooperation Center of the Ministry of Science and Technology;
Top 10 Chinese Ethnic Medicine Brand Enterprises;
Top 50 SME (Small and Medium Enterprise) Board Listed Companies in China;
Top 10 Brands of Traditional Chinese Medicine Products in China;
Top 20 Listed Pharmaceutical Companies in China;
What does Shijiazhuang Yiling Pharmaceutical Co., Ltd. require? Who is Yiling Pharmaceutical hiring? Yiling Pharmaceutical recruitment: Sales占比最多占68.5%,其次是Medical & Health/Beauty & Healthcare占23.5%. What education can get in at Yiling Pharmaceutical? 大专占比最多占60.9%,其次是本科占30.1%. High education required at Yiling Pharmaceutical? 硕士占4.5%,博士占0.8%. Work experience required at Yiling Pharmaceutical? 1-3年占比最多占50.7%,其次是3-5年占17.1%. Where are the job locations at Yiling Pharmaceutical? 石家庄占比最多占21.4%,其次是北京占8.4%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows